Three things to know:
1. The Biofilm Disruption Device delivers low-voltage electricity to a joint replacement implant or other metal inserted into the body.
“Our goal is to eliminate the need for follow-up surgeries. We think we can wipe out infection-causing bacteria before trouble starts,” said Wayne Bacon, president and CEO of Garwood Medical Devices, the Buffalo-based startup developing the biotechnology in conjunction with the University at Buffalo’s Buffalo Institute for Genomics and Data Analytics.
2. The system includes two electrode skin patches, an electricity-generating machine and a needle that carries the electricity to the joint replacement. The needle is inserted into the body, and the electric simulation triggers a chemical reaction at the implant’s surface which is designed to promote an antibacterial micro-environment.
3. When the device was tested in animal models, the technology eradicated up to 98 percent of bacteria associated with joint replacements, according to Mr. Bacon.
More articles on devices:
21 spine devices receive FDA 510(k) clearance in February
FDA recorded 1.1M medical device-related injuries in internal reporting system — 4 things to know
SpineGuard granted patent for spinal ultrasound mapping technology — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
